Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
02186 LUYE PHARMA
RT Nominal down3.650 -0.070 (-1.882%)
Ranking Overview
Hold
Ranking based on 3 research report(s)
Average Ranking 3.00
0
1
1
1
0
Previous Financial Performance
Financial Year 12/2024 EPS 12.54 RMB (cts)
Net Profit 471.89 RMB (MIL) DPS 0.00 RMB (cts)
Consolidation Estimation
Financial Year Profit / (Loss)
(RMB (MIL))
EPS/
((LPS)(RMB (cts))
DPS
(RMB (cts))
Net Asset Value per Share
(RMB)
Highest
(RMB (MIL))
Lowest
(RMB (MIL))
2025740.7020.000--1,016.00575.00
20261,083.9029.000--1,163.00735.00
2027898.0024.000--898.00898.00
Profit Estimation
Profit Estimation Profit / (Loss)
(RMB (MIL))
EPS*/
(LPS) (RMB (cts))
DPS *
(RMB (cts))
Broker Ranking Target Price*
(HKD)
Update Date
2025740.7020.00--GOLDMAN SACHSNeutral3.13 13/03/2025
2025575.0015.00--CITIGROUPBuy3.10 02/04/2025
20251,016.0027.00--MORGAN STANLEYUnderweight3.00 31/03/2025
 
20261,083.9029.00--GOLDMAN SACHS----13/03/2025
2026735.0020.00--CITIGROUP----02/04/2025
20261,163.0031.00--MORGAN STANLEY----31/03/2025
 
2027898.0024.00--CITIGROUP----02/04/2025
Remarks:  Average rating ranges from 1 to 5. The lower the figure, the higher the rating and the vice versa.
  *EPS, DPS and Estimated Price would be adjusted upon Consolidation, Split and Bonus Issue
  Real time quote last updated: 22/07/2025 18:00
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service